Trial NCT01887587

View at ClinicalTrials.gov 
Org. Study IDs: PRO00020384

Last trial update was posted on 2020-01-22

MeSH Interventions

Dexamethasone Doxorubicin Ixazomib Vincristine

MeSH Conditions

Acute Disease Leukemia Leukemia, Lymphoid Lymphoma Lymphoma, Non-Hodgkin Precursor Cell Lymphoblastic Leukemia-Lymphoma

Other Conditions

Mixed Phenotype Acute Leukemia Relapsed or Refractory Acute Lymphoblastic Leukemia Relapsed or Refractory Lymphoblastic Lymphoma

Stopping Reasons

SAE- risk of overall protocol treatment outweighs benefits

Limitations And Caveats

N/A

Result Publications

N/A

Annotations

Category Annotations
No annotators decided on categories yet

Intervention Annotations
# Outdated Intervention Condition
Name Route DrugBank ID